AlphaStocks
5.1
Consider Buy

Harmony Biosciences Holdings, Inc. (HRMY)

Health Care / Biotechnology

S&P SmallCap 600

$37.37

Below average on several measures. Research carefully.

Consider Buy

Score based on 5 of 5 models — high confidence

#517out of 1121 in Health Care

Is Harmony Biosciences Holdings, Inc. a Good Investment in 2026?

Harmony Biosciences Holdings, Inc. (HRMY) scores 5.1 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Lynch model rates Harmony Biosciences Holdings, Inc. as Strong (PEG 0.2 · Fast Grower). The Graham model is the least favorable, rating it Neutral. Harmony Biosciences Holdings, Inc. ranks #517 out of 1121 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E13.8ROE18.6Market Cap2B

Valuation

Trades at 14x earnings — near sector median of 27x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

24% above fair value

Lynch

Strong

PEG 0.2 · Fast Grower

Greenblatt

Strong

Top 25% (rank 19%)

Frequently Asked Questions

Is Harmony Biosciences Holdings, Inc. (HRMY) a good investment?
Based on AlphaStocks' composite analysis, Harmony Biosciences Holdings, Inc. (HRMY) scores 5.1 out of 10, earning a Consider Buy rating. This score is below average, suggesting caution. Trades at 14x earnings — near sector median of 27x.
What is Harmony Biosciences Holdings, Inc.'s Piotroski F-Score?
Harmony Biosciences Holdings, Inc.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is HRMY overvalued or undervalued?
A precise fair value estimate is not available for HRMY. Trades at 14x earnings — near sector median of 27x.
How does HRMY compare to other Health Care stocks?
Harmony Biosciences Holdings, Inc. ranks #517 out of 1121 stocks in the Health Care sector, placing it in the top 46% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about HRMY?
AlphaStocks evaluates HRMY using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Neutral; Lynch: Strong; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 5.1/10.

Similar Stocks

PARRBFAMAZN

Compare HRMY with

HRMY vs PARRHRMY vs BFAMHRMY vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer